who discovered glp-1 agonists GLP-1 receptor agonists and next-generation
Description
although albuminuria is a clinically meaningful biomarker and treatment target, it remains a surrogate endpoint and does not, by itself, prove reduction in kidney failure or need for kidney replacement therapy
In high-fat diet-induced diabetes mice, administration of liraglutide activated pancreatic and duodenal homeobox-1 (Pdx-1), an essential regulator of proliferation and function of pancreatic -cells [56]
Christensen, M., Knop, F
PEIA opted to pause the program in 2024 citing a $1.3 million per month price tag, inclusive of rebates
Expanding Pipeline The GLP-1 pipeline is rich with new indications for existing FDA approved drugs as well as new market entrants
